Skip to main content
UniHealth

Doctor search

Masumi George Asahi, DO

Ophthalmology · Santa Ana

NPI 1962963769

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
7 years
Graduated 2019

Offices

2 locations · Serve the People, Inc. · Retina Macula Institute

Looking this up.

Hospitals listed: Uci Health-Orange. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Asahi’s office to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Uci Health-OrangeOrange, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Chao Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.44 (3.82 to 7.06) · 2,934 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 82.98 (46.2 to 119.76) · 170 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.422, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.56, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.547, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.356, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.449, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 1,287 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Uci Health-Orange

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Uci Health-Orange
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.44 (3.82 to 7.06) · 2,934 casesWorseJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths82.98 (46.2 to 119.76) · 170 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.422BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.56BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.547BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.356BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.449BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1) · 1,287 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.25 to 1.87) · 2,297 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.67 to 1.13)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.3 · 60 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 59 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.2 · 104 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.3 · 331 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.1 · 416 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.4 · 330 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 4,269 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.14 (0 to 0.33) · 8,263 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.19 (0.01 to 0.37) · 8,703 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.95 (0.57 to 3.32) · 1,647 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.52 (1.33 to 3.71) · 2,756 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.15 (2.82 to 11.48) · 1,643 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.78 (2.24 to 7.33) · 1,680 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.98 (0.61 to 3.36) · 871 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.28 (0 to 0.77) · 7,232 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.5 · 170 casesNoneApr 2023 – Mar 2025
SSI - Abdominal HysterectomyInfections0.546No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.6 · 165 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.8 · 556 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits75.5 · 113 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits0 · 391 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-4.4 · 436 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 556 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.1 to 6.6) · 846 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.8 (10 to 14) · 846 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.8 · 200 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.9 · 64 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21 · 110 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.8 (8.6 to 13.8) · 2,457 casesNo differentJan 2022 – Dec 2024

What patients said (575 patients answered, 16% of those asked)

Patient survey stars by topic at Uci Health-Orange
Cleanliness3
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness1
Recommend hospital3
Share of patients giving the best answer at Uci Health-Orange
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well74%
Staff "always" explained57%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully72%
Doctors "always" treated them with courtesy and respect81%
Patients who gave a rating of "9" or "10" (high)65%
Staff "always" explained new medications69%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully69%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night40%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects45%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$11,860

Medicare paid this office $11,860 for 82 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Removal of eye fluid (vitreous) between lens and retina18$2,082$116

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure20232024
Removal of eye fluid (vitreous) between lens and retina–18

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

82 Original Medicare patients in 2024. Average age 73 · Women 54% · Also on Medicaid 32% · Health risk score 1.53. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 41% · Chronic kidney disease 34% · Coronary heart disease 30% · Depression 22% · Cancer 21% · Heart failure 20% · Stroke 17% · Atrial fibrillation 16%.

The office billed $125,292, Medicare allowed $15,055 and paid $11,860; for 112 services of 22 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202482112731.53$125,292$11,860
20233849731.79$45,148$4,220

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

Medicaid work

$83,734 in 2024

Medicaid paid $83,734 for 851 billed services this clinician did in 2024, up to 52 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)105$47,432
Return visit (30+ min)355$24,062
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina356$10,073
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES35$2,166
Medicaid work by year
2024851452$83,734
2023613456$64,220
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)109$42,263
Return visit (30+ min)221$14,363
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina269$7,219
Short return visit (20+ min)14$376

Drugs they prescribed that Part D paid

$56,840

Pharmacies billed $56,840 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 374) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

191 generic and 183 brand-name prescriptions · $56,840 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Restasis11$15,362$1,397
Cyclosporine14$9,742$696
Prolensa19$8,772$462
Bromfenac11$1,879$171
Prednisolone Acetate55$1,858$34
See all 11 drugs
Every Part D drug this clinician prescribed
Restasis11$15,362$1,397
Cyclosporine14$9,742$696
Prolensa19$8,772$462
Bromfenac11$1,879$171
Prednisolone Acetate55$1,858$34
Timolol Maleate16$1,833$115
Brimonidine Tartrate-Timolol11$730$66
Dorzolamide-Timolol46$714$16
Ketorolac Tromethamine39$710$18
Latanoprost40$353$9
Brimonidine25$302$12

Year by year

Part D prescribing by year
20243741230% (0)49%$56,840
20232931340% (0)40%$64,823
20222201080% (0)40%$48,352
20214401500% (0)33%$92,820
2020131580% (0)44%$23,884

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 9 drugs

Part D drugs prescribed in 2023
Restasis11$14,868$1,352
Rhopressa14$8,118$580
Travoprost14$5,554$397
Latanoprost50$1,536$31
Prednisolone Acetate33$1,230$37
Dorzolamide-Timolol34$1,077$32
Timolol Maleate22$946$43
Ketorolac Tromethamine18$406$23
Brimonidine17$403$24

2022: 6 drugs

Part D drugs prescribed in 2022
Travoprost11$4,556$414
Latanoprost46$1,616$35
Prednisolone Acetate28$1,610$57
Dorzolamide-Timolol12$803$67
Ketorolac Tromethamine17$758$45
Timolol Maleate17$606$36

2021: 11 drugs

Part D drugs prescribed in 2021
Restasis14$15,427$1,102
Combigan24$13,018$542
Travoprost31$11,915$384
Alphagan P12$6,176$515
Brimonidine26$3,944$152
Latanoprost108$3,515$33
Timolol Maleate37$1,843$50
Dorzolamide-Timolol27$1,706$63
Dorzolamide26$1,240$48
Prednisolone Acetate25$1,138$46
Erythromycin15$238$16

2020: 2 drugs

Part D drugs prescribed in 2020
Latanoprost23$1,036$45
Prednisolone Acetate22$971$44

Money from drug and device companies

$755 in 2025

Industry payments by year
2025718None$755
2024819None$1,337
2023711None$371

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Regeneron Healthcare SolutionsEylea Hd$188
4 payments
  • Meals for Eylea Hd · 2025-09-17 · $10
  • Meals for Eylea Hd · 2025-09-17 · $38
  • Meals for Eylea Hd · 2025-02-27 · $21
  • Meals for Eylea Hd · 2025-02-07 · $120
AbbvieOzurdex$188
4 payments
  • Meals for Ozurdex · 2025-10-13 · $22
  • Meals for Ozurdex · 2025-06-26 · $16
  • Meals for Ozurdex · 2025-03-27 · $22
  • Meals for Ozurdex · 2025-03-13 · $127
Astellas Pharma USIzervay$157
6 payments
  • Meals for Izervay · 2025-11-25 · $22
  • Meals for Izervay · 2025-11-20 · $13
  • Meals for Izervay · 2025-10-13 · $11
  • Meals for Izervay · 2025-08-01 · $75
  • Meals for Izervay · 2025-05-06 · $14
  • Meals for Izervay · 2025-02-05 · $22
Astellas Pharma Global DevelopmentIzervay$117
1 payment
  • Meals for Izervay · 2025-02-19 · $117
Merz PharmaceuticalsXeomin$46
1 payment
  • Meals for Xeomin · 2025-02-08 · $46
Apellis PharmaceuticalsSyfovre$33
1 payment
  • Meals for Syfovre · 2025-10-29 · $33
See all 18 published payments
Every published payment
ANI PharmaceuticalsMeals · 2025-12-08Iluvien$26
Astellas Pharma USMeals · 2025-11-25Izervay$22
Astellas Pharma USMeals · 2025-11-20Izervay$13
Apellis PharmaceuticalsMeals · 2025-10-29Syfovre$33
AbbvieMeals · 2025-10-13Ozurdex$22
Astellas Pharma USMeals · 2025-10-13Izervay$11
Regeneron Healthcare SolutionsMeals · 2025-09-17Eylea Hd$10
Regeneron Healthcare SolutionsMeals · 2025-09-17Eylea Hd$38
Astellas Pharma USMeals · 2025-08-01Izervay$75
AbbvieMeals · 2025-06-26Ozurdex$16
Astellas Pharma USMeals · 2025-05-06Izervay$14
AbbvieMeals · 2025-03-27Ozurdex$22
AbbvieMeals · 2025-03-13Ozurdex$127
Regeneron Healthcare SolutionsMeals · 2025-02-27Eylea Hd$21
Astellas Pharma Global DevelopmentMeals · 2025-02-19Izervay$117
Merz PharmaceuticalsMeals · 2025-02-08Xeomin$46
Regeneron Healthcare SolutionsMeals · 2025-02-07Eylea Hd$120
Astellas Pharma USMeals · 2025-02-05Izervay$22
See earlier years (2024, 2023)

2024: $1,337

Payments by company in 2024
AbbvieOzurdex$332
4 payments
  • Meals for Ozurdex · 2024-10-02 · $87
  • Meals for Ozurdex · 2024-09-25 · $98
  • Meals for Ozurdex · 2024-06-17 · $124
  • Meals for Ozurdex · 2024-01-23 · $23
Astellas Pharma USIzervay$301
4 payments
  • Meals for Izervay · 2024-11-06 · $119
  • Meals for Izervay · 2024-07-25 · $33
  • Meals for Izervay · 2024-06-04 · $34
  • Meals for Izervay · 2024-04-24 · $114
Dutch Ophthalmic USAEva, Combined Machine$222
2 payments
  • Meals for Eva, Combined Machine · 2024-08-19 · $166
  • Meals for Eva, Combined Machine · 2024-08-08 · $56
Regeneron Healthcare SolutionsEylea Hd$160
4 payments
  • Meals for Eylea Hd · 2024-09-17 · $14
  • Meals for Eylea Hd · 2024-08-31 · $108
  • Meals for Eylea Hd · 2024-06-28 · $33
  • Meals for Eylea Hd · 2024-02-23 · $6
Apellis PharmaceuticalsSyfovre$154
2 payments
  • Meals for Syfovre · 2024-11-19 · $33
  • Meals for Syfovre · 2024-07-31 · $121
Genentech USAVabysmo$122
1 payment
  • Meals for Vabysmo · 2024-05-15 · $122
Alcon VisionClareon$25
1 payment
  • Meals for Clareon · 2024-11-12 · $25
GenentechVabysmo$21
1 payment
  • Meals for Vabysmo · 2024-02-28 · $21

2023: $371

Payments by company in 2023
Coherus BiosciencesCimerli$112
1 payment
  • Meals for Cimerli · 2023-12-14 · $112
AbbVieOzurdex$109
4 payments
  • Meals for Ozurdex · 2023-10-11 · $33
  • Meals for Durysta · 2023-09-29 · $31
  • Meals for Ozurdex · 2023-06-01 · $25
  • Meals for Ozurdex · 2023-05-06 · $20
Alimera SciencesIluvien$53
2 payments
  • Meals for Iluvien · 2023-10-27 · $22
  • Meals for Iluvien · 2023-05-19 · $31
Oyster Point PharmaTyrvaya$30
1 payment
  • Meals for Tyrvaya · 2023-05-12 · $30
Astellas Pharma USNone$25
1 payment
  • Meals · 2023-10-20 · $25
Bausch & Lomb AmericasXipere$25
1 payment
  • Meals for Xipere · 2023-08-21 · $25
Regeneron Healthcare SolutionsEylea Hd$18
1 payment
  • Meals for Eylea Hd · 2023-08-30 · $18

Professional record

NPI
1962963769
Licence
CA 20A20765
Group
Serve the People, Inc. · Retina Macula Institute
Gender
Male
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
4589 Via Marisol Unit 358, Los Angeles, CA, 90042
NPI first listed
2019-03-26
NPI last updated
2023-10-09
NPI record certified
2023-05-09

This is when the NPI record was last certified, not a medical board exam.